Antiapoptotic factor humanin is expressed in normal and tumoral pituitary cells and protects them from TNF-α-induced apoptosis.
Gottardo. María Florencia MF; Jaita. Gabriela G; Magri. María Laura ML; Zárate. Sandra S; Moreno Ayala. Mariela M; Ferraris. Jimena J; Eijo. Guadalupe G; Pisera. Daniel D; Candolfi. Marianela M; Seilicovich. Adriana A
Key Findings
- Humanin is expressed in normal rat anterior pituitary cells, especially lactotropes and somatotropes.
- Its expression is higher in males and is reduced by estrogen in both male and female pituitary cells.
- Humanin (0.5 µM) completely blocks TNF‑α‑induced apoptosis in normal and tumor pituitary cells.
Practical Outcomes
- Humanin may help safeguard pituitary cells against inflammatory damage, hinting at possible benefits for hormone health and stress resilience. However, the work is in rats and cell lines, so no dosing or supplement advice can be drawn yet. Enthusiasts should watch for human studies before considering it for pituitary support.
Summary
Humanin, a tiny protein, is naturally made in the front part of the pituitary gland in rats and can stop cells there from dying when they’re attacked by an inflammation signal (TNF‑α). Males make more of it than females, and estrogen lowers its production in normal pituitary cells, but not in tumor cells. The peptide also works in a pituitary tumor cell line, protecting those cells from the same death signal.
Abstract
Humanin (HN) is a 24-amino acid peptide with cytoprotective action in several cell types such as neurons and testicular germ cells. Rattin (HNr), a homologous peptide of HN expressed in several adult rat tissues, also has antiapoptotic action. In the present work, we demonstrated by immunocytochemical analysis and flow cytometry the expression of HNr in the anterior pituitary of female and male adult rats as well as in pituitary tumor GH3 cells. HNr was localized in lactotropes and somatotropes. The expression of HNr was lower in females than in males, and was inhibited by estrogens in pituitary cells from both ovariectomized female and orquidectomized male rats. However, the expression of HNr in pituitary tumor cells was not regulated by estrogens. We also evaluated HN action on the proapoptotic effect of TNF-α in anterior pituitary cells assessed by the TUNEL method. HN (0.5 µM) per se did not modify basal apoptosis of anterior pituitary cells but completely blocked the proapoptotic effect of TNF-α in total anterior pituitary cells, lactotropes and somatotropes from both female and male rats [corrected]. Also, HN inhibited the apoptotic effect of TNF-α on pituitary tumor cells. In summary, our results demonstrate that HNr is present in the anterior pituitary gland, its expression showing sexual dimorphism, which suggests that gonadal steroids may be involved in the regulation of HNr expression in this gland. Antiapoptotic action of HN in anterior pituitary cells suggests that this peptide could be involved in the homeostasis of this gland. HNr is present and functional in GH3 cells, but it lacks regulation by estrogens, suggesting that HN could participate in the pathogenesis of pituitary tumors.
Study Information
pubmed
2014
2014-10-31T00:00:00.000Z
10.1371/journal.pone.0111548
26
52